Broadwood Partners opposes STAAR Surgical sale to Alcon

Go back to Broadwood Partners opposes STAAR Surgical sale to Alcon

Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical’s Sale to Alcon

October 3, 2025 6:00 AM EDT

Broadwood Believes the Transaction Comes at the Wrong Time, After the Wrong Process, and at the Wrong Price

For the Reasons Described in the Presentation, Broadwood Urges All Stockholders to Vote AGAINST the Proposed Merger

NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (collectively, Broadwood), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA), today announced that it has published a presentation outlining why stockholders should vote on Broadwoods... More